Shares of Allegro Microsystems fell 8% to $30.38 on October 30, the day after the chipmaker posted fiscal second-quarter results that topped Wall Street on every key metric — and still disappointed investors with what comes next. The sell-off highlights a market now demanding accelerating growth, not just good-enough numbers, from a stock that had rallied sharply off its lows.
A Clean Beat Wasn't Enough to Hold the Stock
Q2 sales hit $277 million, up 29% year-over-year, while non-GAAP EPS doubled to $0.26.
Both figures beat consensus — EPS by $0.02 and revenue by roughly $6 million. Yet the stock cratered because investors were pricing in acceleration, not moderation. Q3 guidance of $278–$288 million implies only 23% year-over-year growth at the midpoint — a six-point deceleration from the quarter just reported. For a stock trading at a P/E above 500x trailing GAAP earnings, the bar is punishing.
Analysts Still Like the Story but Are Lowering the Price A wave of target cuts followed the report. Mizuho slashed its target from $58 to $46.
Needham cut from $57 to $50, keeping a Buy rating.
Wells Fargo went from $45 to $40.
Barclays trimmed from $48 to $45 with an equal-weight rating. The message: the bull case is intact but the timeline is stretching. The consensus target now sits around $49 , still well above the current price, but materially lower than a quarter ago.
Data Center Strength Masks a Key Delay
Data center sales hit a record $46 million, up over 150% year-over-year , and the company remains on track to more than double that segment for the full fiscal year. But not everything is going to plan: management acknowledged some large hyperscaler 800-volt programs have been delayed by one to two quarters. Those delays partially explain the softer Q3 trajectory and inject uncertainty into what had been the stock's most compelling growth engine.
Margin Progress and Robotics Offer a Longer Runway
Gross margin improved to 51.5%, up 190 basis points from a year earlier , with management targeting over 55% longer-term through price increases and manufacturing cost shifts. The company will begin sampling a new chip for humanoid robotic hands in Q3 — a tiny but symbolic move into a market investors are watching closely. Design wins hit their highest level since the 2020 IPO, up nearly 40% year-over-year , signaling future revenue that hasn't yet shown up in the top line.
The bottom line: Allegro's fundamentals are clearly improving, but the stock's valuation demands perfection. Until growth re-accelerates or margins expand faster, the gap between narrative and price may keep widening.